MedPath
NMPA Approval

琥乙红霉素

国药准字H33020152

July 3, 2020

Drug Information

琥乙红霉素

原料药

化学药品

July 3, 2020

Company Information

Manufacturing Company

浙江省金华市婺城区定业新村

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

琥乙红霉素 - NMPA 批准文号 | MedPath